Drug name - Natesto

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8784882 ACERUS Controlled release delivery system for nasal applications and method of treatment Feb, 2024

(1 year, 4 months from now)

US8877230 ACERUS Controlled release delivery system for nasal applications Feb, 2024

(1 year, 4 months from now)

US8574622 ACERUS Controlled release delivery system for nasal applications Feb, 2024

(1 year, 4 months from now)

US8784869 ACERUS Controlled release delivery system for nasal applications and methods of treatment Feb, 2024

(1 year, 4 months from now)

US11090312 ACERUS Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event Mar, 2034

(11 years from now)

Drugs and Companies using TESTOSTERONE ingredient

Treatment: A method of testosterone replacement therapy comprising the step of nasally administering to a patient in need of such treatment an effective amount of testosterone gel formulation.; Nasal administration of a testosterone gel to a patient to treat the patient for a condition associated with a deficiency or absence of endogenous testosterone

Dosage: GEL, METERED;NASAL

More Information on Dosage
Strength Dosage Availability
5.5MG/0.122GM ACTUATION GEL, METERED;NASAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.